Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Related Citations for PubMed (Select 21505458)


Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.

Thomas ZI, Gibson W, Sexton JZ, Aird KM, Ingram SM, Aldrich A, Lyerly HK, Devi GR, Williams KP.

Br J Cancer. 2011 May 10;104(10):1575-86. doi: 10.1038/bjc.2011.133. Epub 2011 Apr 19.


XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.

Allensworth JL, Aird KM, Aldrich AJ, Batinic-Haberle I, Devi GR.

Mol Cancer Ther. 2012 Jul;11(7):1518-27. doi: 10.1158/1535-7163.MCT-11-0787. Epub 2012 Apr 16.


Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.

Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE.

PLoS One. 2013 Sep 11;8(9):e73464. doi: 10.1371/journal.pone.0073464. eCollection 2013.


X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.

Aird KM, Ghanayem RB, Peplinski S, Lyerly HK, Devi GR.

Mol Cancer Ther. 2010 May;9(5):1432-42. doi: 10.1158/1535-7163.MCT-10-0160. Epub 2010 Apr 20.


Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.

Yu D, Shin HS, Lee YS, Lee D, Kim S, Lee YC.

Oncol Rep. 2014 Feb;31(2):673-8. doi: 10.3892/or.2013.2893. Epub 2013 Dec 2.


Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.

Victor BC, Anbalagan A, Mohamed MM, Sloane BF, Cavallo-Medved D.

Breast Cancer Res. 2011;13(6):R115. doi: 10.1186/bcr3058. Epub 2011 Nov 17.


TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

Wang X, Saso H, Iwamoto T, Xia W, Gong Y, Pusztai L, Woodward WA, Reuben JM, Warner SL, Bearss DJ, Hortobagyi GN, Hung MC, Ueno NT.

Cancer Res. 2013 Nov 1;73(21):6516-25. doi: 10.1158/0008-5472.CAN-13-0967. Epub 2013 Sep 6.


Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.

Hillyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A.

Clin Exp Metastasis. 2012 Dec;29(8):971-9. doi: 10.1007/s10585-012-9486-0. Epub 2012 May 20.


Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway.

Ohshiro K, Bui-Nguyen TM, Divijendra Natha RS, Schwartz AM, Levine P, Kumar R.

Int J Biol Markers. 2012 Dec 27;27(4):e305-13. doi: 10.5301/JBM.2012.10437.


EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.

Mu Z, Li H, Fernandez SV, Alpaugh KR, Zhang R, Cristofanilli M.

J Exp Clin Cancer Res. 2013 Sep 27;32:70. doi: 10.1186/1756-9966-32-70.


Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.

Allensworth JL, Sauer SJ, Lyerly HK, Morse MA, Devi GR.

Breast Cancer Res Treat. 2013 Jan;137(2):359-71. doi: 10.1007/s10549-012-2352-6. Epub 2012 Dec 7.


Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.

Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya KS, Welch DR, Frost AR.

Clin Exp Metastasis. 2011 Jun;28(5):437-49. doi: 10.1007/s10585-011-9382-z. Epub 2011 Mar 27.


NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Fu J, Rodova M, Nanta R, Meeker D, Van Veldhuizen PJ, Srivastava RK, Shankar S.

Neuro Oncol. 2013 Jun;15(6):691-706. doi: 10.1093/neuonc/not011. Epub 2013 Mar 12.


Inflammatory breast cancer (IBC): clues for targeted therapies.

Fernandez SV, Robertson FM, Pei J, Aburto-Chumpitaz L, Mu Z, Chu K, Alpaugh RK, Huang Y, Cao Y, Ye Z, Cai KQ, Boley KM, Klein-Szanto AJ, Devarajan K, Addya S, Cristofanilli M.

Breast Cancer Res Treat. 2013 Jul;140(1):23-33. doi: 10.1007/s10549-013-2600-4. Epub 2013 Jun 21.


Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Aug 25;9:298. doi: 10.1186/1471-2407-9-298.


Immunologic targeting of FOXP3 in inflammatory breast cancer cells.

Nair S, Aldrich AJ, McDonnell E, Cheng Q, Aggarwal A, Patel P, Williams MM, Boczkowski D, Lyerly HK, Morse MA, Devi GR.

PLoS One. 2013;8(1):e53150. doi: 10.1371/journal.pone.0053150. Epub 2013 Jan 14.


Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.

Cao X, Geradts J, Dewhirst MW, Lo HW.

Oncogene. 2012 Jan 5;31(1):104-15. doi: 10.1038/onc.2011.219. Epub 2011 Jun 13.


Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.

Guo J, Gao J, Li Z, Gong Y, Man X, Jin J, Wu H.

Cancer Lett. 2013 Oct 10;339(2):185-94. doi: 10.1016/j.canlet.2013.06.010. Epub 2013 Jun 18.


GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.

Fu J, Rodova M, Roy SK, Sharma J, Singh KP, Srivastava RK, Shankar S.

Cancer Lett. 2013 Mar 1;330(1):22-32. doi: 10.1016/j.canlet.2012.11.018. Epub 2012 Nov 28.


Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.

Singh RR, Cho-Vega JH, Davuluri Y, Ma S, Kasbidi F, Milito C, Lennon PA, Drakos E, Medeiros LJ, Luthra R, Vega F.

Cancer Res. 2009 Mar 15;69(6):2550-8. doi: 10.1158/0008-5472.CAN-08-1808. Epub 2009 Feb 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk